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Abstract
Amniotic fluid stem cells (AFSc) are a very heterogeneous subtype of stem cells with a broad multi potential. 
They could be used to treat congenital malformations or diseases. Recently, mesoangioblasts, resident pericytes of 
skeletal muscles, were shown to undergo muscle differentiation in vitro and in vivo. In this study we focused on the 
identification of an AFS subtype with pericytic characteristics and evaluate its myogenic potential.
We identified monoclonal AFSc lines expressing alkaline phosphatase activity (ALP) and the canonical pericytic 
markers neural-glial-2 chondroitin sulphate proteglycan (NG2), platelet derived growth factor receptor α and β 
(PDGFR-α, -β) and α smooth muscle actin (α-SMA). These cells were able to integrate into the newly formed myotubes 
when co-cultured with the C2C12 cells. To test the paracrine effects of these AFSC on muscle regeneration, we 
assessed their affects in a transwell assay with acutely injured myotubes. AFSc were able to modulate the expression 
of specific growth factors involved in muscle regeneration, such as Transforming Growth Factor β (Tgfβ), Interferon 
γ (Ifnγ), Hepatocyte Growth Factor (Hgf) and Matrix Metalloproteinase 2 (Mmp2). When AFSc were injected in 
injured muscles they ameliorated muscle repair as measured by the reduction of centronucleated fibers and fibrosis. 
Interestingly, the transcriptional program of growth factor response in vitro is observed in large part in the in vivo 
xenograft experimental model, with the extension of Myostatin and Matrix Metalloproteinase 9 (Mmp9).
Our data suggest that AFSc subtype with pericytic characteristics have the ability to modulate muscle regeneration 
in vitro and in vivo.
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Introduction
In recent years, stem cells derived from amniotic fluid have drawn 
much attention in treatment of congenital and acquired perinatal 
conditions [1]. Amniotic fluid stem cells (AFSc) approximately 
constitute 1% of the cells found in the amniotic fluid (AF). AFSc are 
a heterogeneous population of cells with multipotent characteristics, 
retaining the ability to differentiate into different lineages such as 
adipogenic, chondrogenic, osteogenic and neurogenic [2-4]. The origin 
of these cells remains unknown. Several methods of AFSc isolation 
have been described and the isolation method probably influences 
the characteristics and differentiation potential of AFSs. AFSc can 
be cultured as a heterogeneous population [5] or isolated from early 
colonies consisting of two morphologically distinct adherent cell types, 
termed as spindle-shaped (SS) and round-shaped (RS) [6]. A small 
fraction of cells have been isolated for the expression of the marker 
c-Kit (stem cell factor receptor) [2] and shown to be positive for 
pluripotency markers [7-11]. AFSc integrated and participated in the 
regeneration of damaged organs, such as lung [12], kidney [13], heart 
[14,15] and liver [16,17]. However, aforementioned methodologies 
do not distinguish among AFSc origins. A potential answer to this 
unsolved question is to derive a monoclonal population of stem cells 
by means of a single “starter cell” method. AFSc colonies derived from 
one single cell in primary culture were mechanically selected to derive 
a monoclonal population [18,19]. The advantage of this methodology 
is the possibility of obtaining a monoclonal population of cells at a very 
early stage in culture and of studying its origin. We recently described a 
monoclonal subtype of AFSc that expresses markers that are also found 
in the fetal urinary system [20]. These cells were able to attenuate the 
pathological changes of renal ischemia in a rat model.
The great potential of AFSc is the possibility of an autologous 
approach for congenital malformation or predictable neonatal acquired 
conditions, a research topic of our group. At present, Congenital 
Diaphragmatic hernia (CDH) is one of the few conditions where the 
therapeutic potential of these cells has been investigated [21]. It is a 
malformation resulting in a diaphragmatic defect, with subsequent 
lung hypoplasia. Both these aspects could benefit from cellular therapy 
either by paracrine effects or by construction of a bioengineered 
patch for closure (necessary in around 40% of patients). Currently, 
synthetic and biodegradable patches are used to close the defect with 
high recurrence rates [22]. However, a tissue-engineered patch with 
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addition of stem cells could provide a more effective and long-lasting 
solution [23,24]. 
In this study, we focused on the identification of a AFSc pool suitable 
for muscle repair. Recently mesangioblast, a pericytic sub-population 
of mesenchymal-like cells that associated with the microvasculature 
wall, have been shown to be able to undergo the skeletal muscle lineage 
and restore muscle functionality [25,26]. Herein we demonstrate that 
some AFS pools show pericytic characteristics hence have the ability 
to integrate in myotubes in vitro and to improve muscle regeneration 
process in a mouse model of acute muscle damage in vivo.
Materials and Methods
AFSc culture and characterization
Human AFSc were derived and characterized following previously 
reported conditions [18]. Briefly, amniotic fluid (AF) was received 
from consenting women between 15-22 weeks of pregnancy (research 
program approved by the Ethics Committee of the UZ Leuven). AF was 
filtered with a 40 µm strainer (BD bioscience, Erembodegem, Belgium) 
and centrifuged. The cell pellet was re-suspended in expansion 
medium consisting of α-MEM (Invitrogen, Ghent, Belgium), 15% 
foetal bovine serum (Invitrogen, Ghent, Belgium), 1% L-glutamine 
(Invitrogen, Ghent, Belgium), 1% penicillin/streptomycin (Invitrogen, 
Ghent, Belgium) and 18% Chang B and 2% Chang C (Irvine Scientific, 
Brussels, Belgium), plated in a petri dish and incubated at 37°C in 5% 
CO2. As soon as single cells attached to the dish, medium was replaced 
to remove debris and unwanted epithelial cells. All individual cells 
were monitored daily using a light microscope. After a few days, single 
colonies were mechanically transferred into a 96 well plate and further 
expanded. AFSc from passage 4 in culture were characterized using 
flow cytometry analysis (FACS CantoI, BDbioscence, Erembodegem, 
Belgium) and tested for a complete mesenchymal stem cell CD marker 
panel consisting of CD117, CD24, CD90, CD44, CD105, CD73, HLA-
ABC (BD bioscience) and CD29 (Acris, Herford, Germany), HLA-
DR (BD bioscience) and for the hematopoietic markers CD34 and 
CD45 (BD bioscience) mouse anti-human monoclonal antibodies 
and appropriate isotype controls. The differentiation protocols were 
tested for different mesenchymal lineages (osteogenic, adipogenic and 
chondrogenic) [18]. 
Osteogenic differentiation: Osteogenic differentiation was 
induced by culturing AFSCs at 70% confluence for 4 weeks in 
‘osteogenic differentiation medium’ (Invitrogen). Differentiation was 
assessed by Alizarin staining (Sigma Aldrich, Diegem, Belgium) of the 
calcified extracellular matrix deposition. 
Adipogenic differentiation: To induce adipogenic differentiation, 
cells were cultured at 100% of confluence and subsequently 
differentiated with adipogenic differentiation medium for 14 days at 
37°C in a 5% CO2 incubator. This medium is composed of 10% FBS, 
10-6 M dexamethasone, 0.5 M 3-isobutyl-methylxanthine, 10 mg/mL 
insulin, and 200 mM indomethacin in Dulbecco’s Modified Eagle 
Medium high glucose (Invitrogen). Differentiation into the adipogenic 
lineage was determined by Oil Red O staining (Sigma-Aldrich, MO, 
USA).
Chondrogenic differentiation: To induce chondrogenic 
differentiation, cells were cultured in high-density pellet mass cultures 
for 14 days. 20 mL droplets of cells suspension (400000 cells resuspended 
in phosphate buffered saline) were seeded into individual wells of a 24-
well plate. Cells were allowed to attach without medium for 3 h at 37°C 
in a 5% CO2 incubator and then cultured for 24 h in growth medium. 
24 h later, the medium was replaced with chondrogenic differentiation 
medium (Invitrogen). Chondrogenic differentiation was determined 
by Alcian Blue staining (Sigma-Aldrich).
Cell lines derived from different gestational weeks were tested 
for Alkaline Phosphatase activity by enzymatic colorimetric assay 
(SIGMAFAST BCIP/NBT tablet, Sigma Aldrich, Diegem, Belgium). 
Cells were grown at 100% of confluence and then fixed with 4% of 
PFA for 10 minutes. The staining was then performed following 
manufacturer’s protocol. Signal was  quantified using ImageJ software 
(Colour deconvolution plugin) in order to measure the percentage of 
the area stained.
To test whether AFSc share similar characteristics with pericytes, 
platelet derived growth factor receptor β (PDGFR-β) (clone 958, 
Santa Cruz Biotechnology, Heidelberg, Germany) and α (Millipore, 
Overijse, Belgium), α-smooth muscle actin (αSMA) (Dako, Heverlee, 
Belgium) and neural-glial-2 chondroitin sulphate proteglycan (NG2) 
(Millipore, Overijse, Belgium) were detected by immunofluorescence. 
For the immunofluorescence staining, cells were rinsed twice with cold 
PBS, and then subjected to fixation in 1% PFA in PBS for 10 min at 
room temperature (RT). Cells were then permeabilized with a solution 
containing 0.2% triton and 2% BSA in PBS for 10 min. Unspecific 
reactions were blocked with 10% donkey serum (Sigma Aldrich) in 
PBS for 20 min. Cells were then incubated with primary antibody 
over night at 4°C. After 3 washes 1% BSA in PBS, Alexa Fluor 594 and 
488 secondary antibodies (Life technology, Merelbeke, Belgium) were 
incubated 1 hour at RT. Hoechst (Sigma Aldrich) was used for nuclei 
counterstaining.
Manipulation of AFSC with lentiviral construct
AFSC were manipulated with lentiviral vector (LV) in order to 
express the reporter gene LacZ and GFP as previously described (18). 
Lentiviral production is explained elsewhere [27]. Briefly, lentiviral 
vector particles were added to the cell culture with a multiplicity of 
infection of 10. To detect transduction efficiency in LacZ-AFSC, X-gal 
staining was performed. Cells were fixed in 25% glutaraldehyde and 
37% of methanol for 2 minutes and incubated with a X-gal solution 
(Sigma-Aldrich, Diegem, Belgium) overnight at 37°C. Stained cells 
were counted using light microscopy and expressed as a ‘percentage 
positive’ in relation to the total cell population (% positive cells). To 
detect GFP positive AFSC, flow cytometry analysis was performed. 
AFSC were trypsinezed, washed with PBS and immediately analysed 
with FACS Canto. Untransduced AFSC population was used a negative 
control to design proper gate. 
Differentiation towards muscle lineage
Two populations of AFSc with pericyte characteristics were plated 
on a 24 well plate and grown till confluence. Then growth medium 
was replaced with differentiation medium (DMEM glutamax, sodium 
pyruvate 100 mM, insulin 10 µg/mL, glutamine 1%, transferrin 100 µg/
mL, horse serum 5% and 1% penicillin and streptomycin; all reagents 
from Life Technology, Merelbeke, Belgium) and cells were kept for 
7 days at 37°C in 5% O2, changing medium every 3 days. To detect 
differentiation (myotubes formation), cultures were fixed with 1% PFA 
in PBS for 10 min at RT. Unspecific reactions were blocked with 10% 
donkey serum in PBS for 20 min. Cultures were then incubated with 
primary antibody for Myosin heavy chain II (Mef20, DSHB) over-night 
at 4°C. After 3 washes with 1% BSA in PBS, Alexa Fluor 594 secondary 
antibodies was incubated 1 hour at RT. Hoechst (Life technology, 
Merelbeke, Belgium) was used for nuclei counterstaining.
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Co-culture with murine myogenic cell line C2C12
GFP- and LacZ-AFSc were co-cultured with murine skeletal 
myoblasts (C2C12 cells) in a ratio of 1:3 (C2C12: AFSc), and plated at 
5,000 cells/cm2 in AFSc growth medium.
Forty-eight hours after plating, cells reached 100% confluence 
and growth medium was shifted to differentiation medium (DMEM 
glutamax, sodium pyruvate 100 mM, insulin 10 µg/ml, glutamine 
1%, transferrin 100 µg/ml, horse serum 5% and 1% penicillin 
and streptomycin; all reagents from Life Technologies). Medium 
was replaced every 3 days until the end-point of 7 days. To detect 
differentiation, co-cultures with GFP-AFSc were fixed with 1% PFA 
in PBS for 10 min at RT. Unspecific reactions were blocked with 10% 
donkey serum in PBS for 20 min. Cultures were then incubated with 
primary antibody for myosin heavy chain II (Mef20, Developmental 
Studies Hybridoma Bank (DSHB), Iowa City, Iowa, USA) over-night 
at 4°C. After 3 washes in 1% BSA in PBS, Alexa Fluor 594 secondary 
antibody was incubated 1 hour at RT. Hoechst was used for nuclei 
counterstaining. Co-cultured with LacZ–AFSc and C2C12 were fixed 
in 25% glutaraldehyde and 37% methanol for 2 min and incubated 
with an X-gal solution (Sigma Aldrich) over-night at 37°C followed by 
eosin counterstaining. To detect myotubes structure, incubation with 
myosin heavy chain antibody was used as described above. Secondary 
antibody (goat anti rabbit PO, Dako) was incubated for 1 hour at RT at 
a concentration of 1:100. Biotin-conjugated secondary antibodies were 
detected with HRP-ABC signal amplification Kit followed by DAB 
detection. Micrographs of DAB-stained cells were directly taken with a 
phase contrast microscope (Leica).
Myogenic modulation of AFSc in vitro 
To test the modulation capacity of AFSc on damaged C2C12, 
a paracrine indirect co-culture assay was designed. C2C12 were 
seeded on a 24 well plate and cultured with differentiation medium 
(DMEM+2%FBS+1%PS) until myotubes were formed. After 7 days, 
cardiotoxin (CTX, 10 µM; Sigma-Aldrich) was added to the culture. 
After 24 hours, cells were washed with PBS and medium was replaced. 
In addition, Transwell® Permeable Supports (pore size 4 µm; Corning, 
Kruibeke, Belgium) with AFSc previously seeded was added to the 
culture. Cell seeding concentrations were selected in order for wells to 
reach confluence by day 1 of the experiment. Twenty-four and 48 hours 
later, C2C12 cells were harvested and RNA extracted to investigate 
expression of specific markers (Table 1).
LDH assay: To prove toxicity of CTX on C2C12 cells, an LDH 
assay (cat n. 88953, Thermo Scientific, Aalst, Belgium) was performed. 
C2C12 were plated and cultured for 7 days in DM until myotubes were 
formed. CTX (10 µM) was added. Twenty-four hours later, the assay 
was performed following manufacturer’s instruction. 
Molecular analysis: RNA from C2C12 cell line was extracted 
using TriPure reagent (Roche, Vilvoorde, Belgium) according to the 
manufacturer’s instructions. cDNA was synthesized from 1 µg of 
RNA using Taq Man Reverse Transcription Reagents according to 
manufacturer’s instructions (Applied Biosytem, Gent, Belgium). The 
SuperScript™ III Platinum® SYBR® Green One-Step qRT-PCR Kit with 
ROX (Invitrogen, Gent, Belgium) was used to detect gene expression 
in samples. Primer sequences are listed in Table 1. Gapdh was used as 
a reference gene to normalize mRNA levels and results were computed 
using the Delta Ct (Ct gene of interest - Ct GAPDH) formula and 
subsequently normalized to the level before differentiation.
AFSc transplanted in CTX-injured skeletal muscle mice
Animals were housed at the animalium of the Faculty of Medicine 
of the Catholic University of Leuven. Animals were kept at constant 
temperatures and humidity, with 12:12-h light-dark cycles and 
unrestricted access to standard diet and water. All experiments were 
performed in cohorts of aged-matched adult C57BL/6 mice. A total 
number of 24 animals was used for this experiment. Mice (n=6/group) 
were randomly assigned as follows: mice subjected to CTX injection 
into the right tibialis anterior (TA) and gastrocnemius (GSC) muscles 
and treated with PBS (50 µL) (= group CTX+PBS); mice subjected to 
CTX injection into the right TA and GSC muscles and treated with 
AFSc (500.000 cells re-suspended in 50 µl of PBS) (= group CTX + 
AFSc). Contralateral TA and GSC muscles were used as internal control 
(= group control). Mice were anesthetized with 1% Isofluorane (ISO-
VET, Eurovet, Heusden-Zolder, Belgium) and CTX (10 µM; Sigma-
Aldrich) was injected into the muscle belly of the TA and GSC of the 
right leg of the animal. Two days later, either PBS or AFSc were injected 
in the damaged area. Entire TA and GSC muscle, from tendon to 
tendon, were harvested at 1 and 2 weeks after injection. Excess fat and 
connective tissue were removed and muscles were quickly weighted. 
TA muscles were fixed in 4% PFA and GSC muscles were snap-frozen 
for molecular analysis.
Histological evaluation: Muscle biopsies were fixed in 4% 
PFA, embedded into paraffin and then sectioned to 4 μm slides and 
processed for H&E staining. Fifteen non-overlapping fields were taken 
from muscle biopsies to count number of centrally nucleated fibers 
compared to the total number of fibers at 1 and 2 weeks.
Immunostaining for laminin was performed on paraffin slides. 
Briefly, sections were deparaffinized and endogenous peroxidase 
activity was blocked with 0.5% H2O2 in PBS for 20 min at room 
temperature. Slides were then heated at 98°C for 1 hour in citrate 
buffer (10 mmol/L, pH 6.0) to enhance antigen retrieval. Non-specific 
binding was minimized by incubating sections in 2% BSA, 1% milk 
in PBS-0.1% tween 80 for 30 min. Sections were then incubated over-
night at 4°C with the primary rabbit polyclonal antibodies against 
laminin at 1:100 dilutions (ab11575, ABcam, Cambridge, UK). 
Negative controls included buffer alone. Secondary antibody (goat 
anti rabbit HRP, Dako) was incubated at 1:100 dilutions for 1 hour. 
The color reaction was developed with 3,3'-diaminobenzidine (Sigma) 
and sections were counterstained with Mayer hematoxylin. Sections 
were then dehydrated through graded ethanol, cleared in xylene, and 
Gene FW RV
Gapdh CGACTTCAACAGCAACTCCCACTCTTCC TGGGTGGTCCAGGGTTTCTTACTCCTT
Hgf CAACAGTAGGGTGGATGGTTAG TGAGCCTTCAGGACCATAGA
Ifn γ TCAAGTGGCATAGATGTGGAAGAA TGGCTCTGCAGGATTTTCATG
Tgf β1 CGCAACAACGCCATCTATGA CAAGGTAACGCCAGGAATTGT
Myostatin CAGGAGAAGATGGGCTGAATC CCTGAGCAGTAATTGGCCTTA
Mmp2 CTACTTCTTCAAGGGTGCCTATT GGAGGAGTACAGTCAGCATCTA
Mmp9 CCCTGCCAGTTTCCATTCA CTGTCAAAGTTCGAGGTGGTAG
Table 1: List of primers used to detect murine sequences.
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differentiation potential or ‘pericyte’-characteristics no ideal clone 
for muscle differentation was selected. To test the in vitro myogenic 
potential of these cells, two different cell lines with high expression 
of both pericytic markers and ALP activity were chosen (clone 1 
and 2) (Figure S1). Moreover, these two specific cell lines had a high 
replication potential and could be expanded in culture for more than 
30 passages. After 7 days under the myogenic differentiation protocol, 
few myotubes were observed in culture (Figure S3) showing a weak 
myogenic differentiation potential in vitro compared to the control 
murine cell line C2C12 (Figure S3). Clone 1 and 2 were further co-
cultured with the murine cell line C2C12 and integration of AFSc into 
the myotube structures was explored. In order to visualize the human 
cells, we used the AFSc that were labelled with the nLacZ or the eGFP. 
After 7 days of differentiation of the co-culture system LacZ-AFSc were 
detected in the newly formed myotubes. We were able to detect blue 
stained nuclei next to unstained nuclei in some myotubes when the 
nLacZ AFSc lines were used. An approximation of 5% of myotubes 
contained positive LacZ-AFSC were counted compared to the total 
number of myotubes formed. In the case of the eGFP-AFSc lines, we 
were able to visualize myotubes with a green cytoplasm (Figure 1).
Myogenic modulation of AFSc in vitro
In order to study a protective paracrine effect of AFSc on damaged 
myoblast, we set an in vitro study were C2C12 were exposed to the toxic 
agent CTX and then cultured in a trans-well assay with AFSc. AFSc 
were able to modulate key gene expression in damaged C2C12 cells. 
mRNA level of the inflammatory cytokine Ifnγ was lower in C2C12 in 
the presence of AFSc, as compared to AFSc-free C2C12 culture, at 24 
and 48 hours (p=0.0022). Hgf and Tgfβ1 expression were also reduced 
at 48 hours (p=0.0022) while at 24 h the expression of this gene was 
still normal in both groups. During muscle regeneration, remodeling of 
the extracellular matrix is an important step. Matrix metalloproteinase 
Mmp2 is implicated in motility, differentiation and regeneration of 
skeletal muscle ﬁbers. In our assay, mRNA of Mmp2 was drastically 
reduced at 48 hours in the trans-well culture compared to the control 
C2C12 (0.67 vs 37.37 fold increase, p=0.0022) while no effect was seen 
at 24 h (Figure 2).
mounted in dePex (BDH, vWR International, Heverlee, Belgium). Ten 
non-overlapping fields were taken using a 200X magnification with a 
Zeiss microscope. Images were captured using the condenser phase 
contrast 1. Cross sectional fiber perimeter of each fiber were automatic 
measured with a MATLAB-based command line software. Software 
was specifically designed to measure cross sectional area (CSA) based 
on the work from Hodneland et al. [28]. The frequency distribution 
of single-fiber CSAs was determined. The single-fiber CSA was then 
divided into the total fiber CSA to provide an estimate of the number 
of fibers present in each muscle.
To detect fibrosis formation muscle section were stained for 
Masson’s trichrome at 1 and 2 weeks after injury. The digital color 
images were segmented (color deconvolution plugin) and further 
binarized in order to measure the percentage of the fibrosis stained in 
blue.
Slides stained by H&E and Masson Trichrome staining were 
evaluated by one researcher and an experienced pathologist (F.B) who 
were blinded to the sample identification. 
PCR analysis: RNA from C2C12 cell line or from the 
gastrocnemius muscles from the three different groups (control, 
CTX+PBS, CTX+AFSc) was extracted using TriPure (Roche) following 
the manufacturer’s instructions. cDNA was synthetized and qPCR 
was performed for Myostatin, Ifnγ, Hgf, Tgfβ1 and Mmp9. Primer 
sequences are listed in Table 1. Gapdh was used as a reference gene 
to normalize mRNA levels and results were computed using the 
Delta Ct (Ct gene of interest - Ct GAPDH) formula and subsequently 
normalized to the level before differentiation.
Statistical analysis
Results were expressed as mean ± SD. Appropriate parametric 
or non-parametric statistical tests were chosen according to data 
distribution (Gaussian or not). qPCR analysis was analyzed using the 
t-test. Linear regression analysis was used to analyze the frequency 
of distribution of the fiber perimeter, while for the number of 
centronuclear fibers nonparametric Kruskal-Wallis followed by Dunn 
testing was used. Statistical significance level was defined as p<0.05. 
Quantification of immunohistochemistry was analyzed using the t-test.
Ethical approval
AFSc isolation was approved by the UZ Leuven Medical Ethics 
committee (project number: ML4149). All procedures involving 
animals were approved by the Local Ethics Committee for Animal 
Experimentation of the Catholic University of Leuven (KU Leuven) 
(project number: P095/2012).
Results
Some monoclonal AFSc lines express pericyte-like markers 
and have a myogenic differentiation potential in vitro
Human monoclonal AFSc isolated from different harvest time 
points (15-21 weeks) invariably expressed canonical mesenchymal stem 
cell markers and were able to differentiate in 3 different mesenchymal 
lineages as previously shown (Figures S1 and S2) [18]. Some AFSc lines 
were variably positive to Alkaline Phosphatase activity (ALP; range: 
0-56%) (Figures 1A, S1(C) and Table 2). Within this population some 
AFSc lines expressed pericytic markers PDGFRβ and α-SMA, and to 
a lower extent PDGFRα (Table 2). The pluripotency marker ALP was 
used as discriminating factor because by mesenchymal characteristics, 
CLONE ALP (%) PDGFR β PDGFR α α-SMA
Clone 1 56.3 + + ++
Clone 2 23.2 ++ - +++
Clone 3 47.2 + - +
Clone 4 48.7 + + ++
Clone 5 37.9 + - +++
Clone 6 4.6 ++ - -
Clone 7 3 + - +++
Clone 8 2.6 + + ++
Clone 9 2.1 + - -
Clone 10 0.8 + - -
Clone 11 0 ++ - -
Clone 12 0.3 nd - +++
Clone 13 0.4 + + +
Clone 14 0 nd - +
Clone 15 0 nd - +
ALP is measured by % of positive stained area. For the expression of PDGFR-α/β 
and α-SMA a score system was used to evaluate the presence of the markers 
visualized by IF: (+) ~25%, (++) ~50% and (+++) >50%. Clone 1 and 2 were used 
for direct co-culture experiments. For the in vivo injection clone 1 was used.
Table 2: Analysis of pericyte markers on 15 different populations of AFSC.
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(A) Representative images of PDGFR α/β, α-SMA, NG2 and for ALP activity in AFSC. (B) Nuclei from LACZ-AFSC are integrated into myotubes structure. Culture are 
counterstained with Eosin or with Mef20. In the right panel is shown the co-culture with GFP-AFSC with C2C12 after 7 days of differentiation.
Figure 1: Characterization of AFSC for pericytes markers and co-culture of AFSC with murine skeletal muscle cell line C2C12.
(A) Schematic representation of the experiment. (B) Representative figures of C2C12 myotubes at d0 and after 48 
hours after incubation with Cardiotoxin. (C) LDH assay shows toxicity on C2C12 cultures 24 hours after CTX 
exposure (p=0.0238). (D) Molecular analysis of damaged myotubes after CTX exposition: qPCR analysis of Hgf, Ifn
γ, Tgfβ1 and Mmp2 expression in damaged myotubes with the addition of AFSC seeded in a trans-well. Three 
independent experiments were performed in triplicates and statistically analyzed using t-Test; Data are presented as 
mean ± SD; *p = 0,0238. **p = 0.022.
Figure 2: In vitro assay to test paracrine effect of AFSC on damaged differentiated C2C12.
(A) Schematic representation of the experiment. (B) Representative figures of C2C12 myotubes at d0 and after 48 hours after incubation with Cardiotoxin. (C) LDH 
assay shows toxicity on C2C12 cultures 24 hours after CTX exposure (p=0.0238). (D) Molecular analysis of damaged myotubes after CTX exposition: qPCR analysis 
of Hgf, Ifnγ, Tgfβ1 and Mmp2 expression in d maged myotubes with th  addition of AFSC seeded in a trans-well. Thre  independent experiments were performed in 
triplicates and statistically analyzed usi g t-Test; Data are presented as mean ± SD; *p = 0,0238. **p = 0.022.
Figure 2: In vitro assay to test paracrine ffe t of AFSC on damag d differentiated C2C12.
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Pericyte-like AFSc improve muscle regeneration in CTX 
injured mice
Having established that AFSc with pericytic characteristics have an 
in vitro paracrine effect in C2C12 CTX-injured culture, we subsequently 
investigated whether AFSc could have a regenerative potential in vivo 
in an acutely damaged muscle. 500,000 cells were injected into the 
muscle belly 48 hours after injection of CTX. Muscle biopsies were 
harvested 1 and 2 weeks after injection of cells. 
Paraffin sections of TA muscles were stained with H&E (Figure 
3A) and number of centronuclear fibers were counted. The appearance 
of centrally nucleated fibers (CNFs) is a characteristic of regenerating 
myofibers. Ratio of CNFs were quantified as it is known that after acute 
muscle injury a better regeneration correspond to a faster disappearance 
of CNFs [29-31]. At 1 week no difference between the two groups was 
observed (CTX+PBS vs CTX + AFSc), while at 2 weeks 50% of the fibers 
were center nucleated in the AFSc-treated group. This was statistically 
different compared to the PBS-treated muscles (50.9 vs 80.87, p<0.001) 
(Figure 3B). Immunohistochemistry for laminin (Figure S4) was used 
for unbiased morphometric measurement. No statistical difference 
was observed in CSA of the muscle between groups (Figure 3C). At 2 
weeks, a slight hypertrophy of the fibers in the AFSc treated animals 
was observed when compared to the PBS group. ASFC-treated animals 
had a higher frequency of fibers in the 150 and 175 µm CSA categories 
as compared to PBS group (150: 23.2 vs 21.9 µm; 175: 17.1 vs 15.69 µm).
The injured muscles showed an inflammatory response in both 
groups (CTX+PBS and CTX+AFSc) with presence of inflammatory cells 
in the endomysium and surrounding the regenerating myocytes, as shown 
by their small size and the presence of centered nuclei (Figure S5). An 
inflammatory assessment by a blinded expert pathologist did not reveal 
any significant differences in inflammatory response between groups. 
Collagen deposition as a marker of early fibrosis was also observed in 
injured muscle. Slides stained for Masson's trichrome showed significant 
less fibrosis in the animals treated with AFSc compared to the PBS group 
(3.58 vs 16.65 % area stained/HPF; p<0.001) (Figure 4). We investigated 
the possible paracrine mechanisms by which the AFSc could exert a 
therapeutic effect on the recovering muscle (Figure 4B). Levels of Tgfβ1, 
Hgf and Myostatin were down-regulated in animals treated with AFSc as 
compared to PBS group (Tgfβ1: p= 0.0036; Hgf: p= 0.0022; Myostatin: 
p= 0.0022). PBS-treated animals showed higher level of the cytokine Ifnγ 
(p= 0.0337) and the matrix metalloproteinase Mmp9 (p= 0.0281), when 
compared to the AFSc-treated group.
Discussion
In this study, we identified monoclonal populations of stem cells 
(A) Representative images of TA muscle sections for the 3 different groups (control, CTX+PBS and CTX+AFSC) stained for H&E at 1 and 
2 weeks. (B) Quantification of the CNF over total fibers (** p<0.001; *** p<0.0001). (C) Fiber percentage distribution among cross‐section-
al area (CSA) classes reveals a shift of AFSC‐treated muscle toward higher CSA values.
Figure 3: Morphological analysis of tibialis anterior muscle sections.
(A) Representative images of TA muscle secti ns for the 3 different groups (control, CTX+PBS and CTX+AFS ) stained for H&E at 1 and 2 weeks. (B) Quantification 
of the CNF over total fibers (** p<0.001; *** p<0.0001). (C) Fiber p rcentage distribution among cross-se tional area (CSA) classes reveals a shift of AFSC-treated 
muscle toward higher CSA values.
Figure 3: Morphological analysis of tibialis anterior muscle sections.
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derived from amniotic fluid that ameliorates damaged myotubes in 
vitro and myofibers regeneration in vivo. Notably, we show that AFSc 
can modulate the expression of important factors for muscle growth 
and regeneration in vitro/in vivo in a paracrine manner. Our data 
contribute to the understanding of the potential of AFSc in injured 
skeletal muscles.
We previously showed that amniotic fluid contains cells that 
express markers that are suggestive for fetal renal origin. These cells 
were also able to attenuate the renal damage in an acute kidney injury 
model [20]. As we isolate the AFSC in such a manner that we are able 
to obtain monoclonal cell lines, we further investigated the entire AFSc 
population to see if other subtypes of cells were present. A certain 
subtype of these monoclonal AFSC express – next to the canonical 
mesenchymal stem cell markers [18] - markers that are also found 
in pericytes. The theory that pericytes are actually local muscle stem 
cells has gained more support in recent years [32,33]. These cells are 
defined as resident stem cells that can be activated and differentiated 
into a specific cell type after organ damage. In the skeletal muscle, 
when sorted for ALP, these cells are designated as mesoangioblasts [34] 
and can undergo skeletal myogenesis in vitro and in vivo [35,36]. We 
showed that a subset of AFSc express ALP and pericyte markers such 
as PDGFR-α and β and α-SMA. Even though these cells could only 
marginally be differentiated into myoblasts or myotubes, they were 
able to integrate into newly formed myotubes in vitro when co-cultured 
with murine myoblasts. Our results differ from previous reports [35], 
that showed myogenic differentiation of AFSc by culturing the cells 
with 5’-azacytidine. This resulted in an up-regulation of MYOD [35], 
yet the formation of myotubes in vitro was not shown. Our different 
findings may be attributed to differences in isolation and culturing 
conditions. 
Since we were able to show the in vitro myogenic differentiation 
potential of AFSc, we also investigated their paracrine effect in vitro. 
We induced cell damage in a murine myoblast culture using CTX, 
then tested the indirect co-culture of AFSc with these murine C2C12 
cells. In our model, the addition of stem cells resulted in changes in 
selected factors that are thought to play a role in muscle proliferation 
and differentiation. High levels of Hgf in cultured myoblasts were 
earlier shown to reduce proliferation and differentiation [36,37]. 
The same effect was obtained with the over-expression of Tgfβ1 and 
Ifnγ [38,39]. In our experiments, AFSc exert a contact-independent 
paracrine effect and modulate the expression levels of these factors. 
During regeneration, remodeling of the extracellular matrix that 
surrounds fibers is vital. Myoblasts can migrate into damaged areas and 
contribute to newly formed myofibers. The matrix metalloproteinase 
Mmp2 is constitutively expressed in muscle tissue, but after injury 
Mmp2 is transiently up-regulated and declines at 10 days post-injury 
(A) Representative images of muscle sections stained for Masson’s trichrome in all 3 groups at 1 week 
(**<0.001; ***, p<0.0001). (B) Molecular analysis of damaged muscle after CTX injection: qPCR analysis of 
Tgfβ1, Ifnγ, Myostatin, Hgf, Igf and Mmp2 mRNA expression in all 3 groups. Data were analyzed using 
t-Test; Data are presented as mean ± SD; *p<0.05.
Figure 4: Histological analysis of injured skeletal muscle and possible paracrine effect of AFSC in muscle 
regeneration.
(A) Representative images of muscle sections stained for Masson’s trichrome in all 3 groups at 1 week (**<0.001; ***, p<0.0001). (B) Molecular analysis of damaged 
muscle after CTX injection: qPCR analysis of Tgfβ1, Ifnγ, Myostatin, Hgf, Igf and Mmp2 mRNA expression in all 3 groups. Data were analyzed using t-Test; Data are 
presented as mean ± SD; *p<0.05.
Figure 4: Histological analysis of injured skeletal muscle and possible paracrine effect of AFSC in muscle regeneration.
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and concomitantly with the generation of new fibers [40]. Intriguingly, 
addition of AFSc resulted in a restoration of Mmp2 expression. From 
this assay we can hypothesize that AFSc have a paracrine effect on 
injured C2C12 and accelerate the healing process. The same pattern 
of expression was observed in CTX-damaged muscles of C57BL/6 
mice. The mRNA expression levels of Myostatin, Ifnγ and Tgfβ1 that 
decreased in the AFSc-treated group are considered a negative regulator 
of muscle growth, proliferation and regeneration [38]. In our study we 
saw a significant decrease of Hgf and Ifnγ expression when animals 
were treated with AFSc. In accordance to our results, in literature it 
is known that Hgf factor is secreted from injured fibers and its level is 
decreasing over time [41], while Ifnγ increased substantially following 
injury, peaking at 5 days post injury [42]. To strengthen the observation 
that AFSC accelerate muscle regeneration, animals treated with AFSc 
showed a decreased number of center nucleated fibers (CNFs) 14 days 
after treatment. 
Fibrosis is the end of a cascade of events following tissue injury via 
inflammation, resulting in scar formation and potentially impairment 
of tissue function. Animals treated with AFSc showed a significant 
lower percentage of collagen deposition, which may indicate less final 
scarring. This observation could be correlated to the significant lower 
level of the pro-fibrotic factor Tgfβ1 and Myostatin in AFSc treated 
muscles. Myostatin has been proved to induce synthesis of ECM 
proteins, such as procollagen (types Iα1, Iα2, and IIIα1) and to act 
synergically with Tgfβ1 to amplify the fibrotic process in injured or 
diseased skeletal muscles resulting in greater fibrosis than either could 
induce individually [43].
In this study we addressed a potential role of AFSc in muscle 
regeneration. Even though we observed a modulation of specific factors, 
the fine mechanisms of the putative short-term paracrine effects remain 
unknown. Despite AFSc are likely not directly committed toward the 
skeletal muscle lineage, we believe that they can exert a paracrine action 
that assists muscle regeneration or activates resident progenitor cells. 
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